Journal article icon

Journal article

Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum

Abstract:
Malaria remains a major infectious disease and, despite incidence reduction, it threatens resurgence in drug-resistant forms. Antimalarial drugs remain the mainstay of therapeutic options and hence there is a constant need to identify and validate new druggable targets. Plasmodium falciparum aminoacyl-tRNA synthetases (Pf-aaRSs) drive protein translation and are potent targets for development of next-generation antimalarials. Here, we detail advances made in structural-biology-based investigations in Pf-aaRSs and discuss their distribution of druggable pockets. This review establishes a platform for systematic experimental dissection of malarial parasite aaRSs as a new focus for sustained drug development efforts against malaria.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.drudis.2018.01.050

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Structural Biology
Role:
Author


Publisher:
Elsevier
Journal:
Drug Discovery Today More from this journal
Volume:
23
Issue:
6
Pages:
1233-1240
Publication date:
2018-02-08
DOI:
EISSN:
1878-5832
ISSN:
1359-6446
Pmid:
29408369


Language:
English
Pubs id:
pubs:823474
UUID:
uuid:1853ec10-9669-4ba1-b224-d914ed01f71f
Local pid:
pubs:823474
Source identifiers:
823474
Deposit date:
2018-05-31

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP